Introduction Prader-Willi syndrome (PWS) is a complex genetic disorder associated with three different genetic subtypes: deletion of the paternal copy of 15q11-q13, maternal UPD for chromosome 15 and imprinting defect. Patients are typically diagnosed because of neonatal hypotonia, dysmorphism and feeding difficulties; however, data on the prenatal features of PWS are limited.
AbsTrACT
Introduction Prader-Willi syndrome (PWS) is a complex genetic disorder associated with three different genetic subtypes: deletion of the paternal copy of 15q11-q13, maternal UPD for chromosome 15 and imprinting defect. Patients are typically diagnosed because of neonatal hypotonia, dysmorphism and feeding difficulties; however, data on the prenatal features of PWS are limited.
Objective the aim of the study was to identify and compare frequencies of prenatal and neonatal clinical features of PWS among the three genetic subtypes. Methods Data from 355 patients with PWS from the rare Diseases clinical research network PWS registry were used to analyse multiple maternal and neonatal factors collected during an 8-year multisite study. results among our cohort of 355 patients with PWS (61% deletion, 36% UPD and 3% imprinting defect) 54% were born by caesarean section, 26% were born prematurely and 34% with a low birth weight (frequencies 32%, 9.6% and 8.1%, respectively, in the general population). Fetal movements were reported as decreased in 72%. all babies were hypotonic, and 99% had feeding difficulties. low apgar scores (<7) were noted in 17.7% and 5.6% of patients, respectively, compared with 1% and 1.4%, respectively, in the general population. Maternal age and pre-pregnancy weight were significantly higher in the UPD group (p=0.01 and <0.001, respectively). Conclusion We found a higher rate of perinatal complications in PWS syndrome compared with the general population. no significant differences in the genetic subtypes were noted except for a higher maternal age and pre-pregnancy weight in the UPD subgroup
InTrOduCTIOn
Lack of expression of genes on the paternally inherited chromosome 15q11-q13 region causes Prader-Willi syndrome (PWS). 1 This complex neurobehavioral condition affects about 1 in 10 000-15 000 live births. 2 Most patients with PWS have a paternal deletion of 15q11-q13 (70%), approximately 25%-30% have maternal UPD 15 and 1%-3% have an imprinting defect (ID). Babies with PWS present with hypotonia, poor suck and feeding difficulties, dysmorphic features and hypogonadism. Later, obesity and hyperphagia result if caloric intake is not controlled.
3-5 These findings may be subtle in the immediate newborn period or may be masked by prematurity and other neonatal complications. [6] [7] [8] Perinatal features of PWS reported in the literature include decreased fetal movements, polyhydramnios, malpresentation and fetal heart rate abnormalities. 6 9-13 These obstetric complications frequently result in assisted vaginal deliveries with forceps or vacuum and caesarean sections. Perinatal features have been described in the literature as clinical reports or small case series. In this study, we aimed to characterise these findings in a large well-studied cohort of 355 subjects enrolled in the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) PWS registry with special emphasis on natural history and genotype-phenotype correlations. The goal of this study was to provide an accurate incidence of the maternal and neonatal features of PWS. We believe that increased awareness among obstetricians and healthcare providers would allow earlier diagnosis and treatment of PWS by paediatricians/neonatologists with subsequent reduction of morbid obesity and other comorbidities impacting on quality of life
MeThOds
We analysed deidentified data from 355 patients with PWS from the RDCRN PWS registry. The registry patients were enrolled by PWS experts following signed consent of Institutional Review Board approved forms at four different clinical sites: University of California, Irvine, CA; Kansas University Medical Center, Kansas City, KS; Vanderbilt University, Nashville, TN; and University of Florida, Gainesville, FL. All data from this registry were managed by the Data Management Coordinating Center in Tampa, FL (DMCC). The DMCC facilitated the generation of electronic forms for data entry, data retrieval and statistical analyses. Our multicentre longitudinal observational natural history study was supported by the NIH. We analysed data on maternal and neonatal features collected through standardised natural history questionnaires completed by the registry team and compared variables to the existing general population with their PWS genetic subtypes ( 
resulTs
The descriptive statistics of maternal and neonatal outcome variables are summarised in table 2. Out of 355 patients with PWS enrolled in the registry, 217 had the 15q11-q13 deletion (61%); of these 98 were male (45.2%) and 119 were female (54.8%); 127 patients had maternal UPD (36%) comprising 52 men (40.9%) and 75 women (59.1%), and 11 had IDs (3%), this group comprised eight men (72.7%) and three women (27.3%).
Seventy-eight per cent of PWS mothers reported decreased fetal movements during their pregnancy and 99.7% of the babies had hypotonia postnatally. Fifty-five per cent of PWS babies were born by caesarean section, significantly higher than the caesarean section rate of 32% for all deliveries in the USA as reported in 2017 by the Centers for Disease Control and Prevention (CDC) 14 (table 2) . We also found a higher incidence of low birthweight babies (34%) in our study group compared with 8.1% incidence of low birth babies in the USA (CDC 2017) 14 (table 2) . We found 5% (16/322) from our individuals had a very low birth weight (<1500 g). The 5% incidence of very low birthweight babies in this PWS group is approximately three times higher than the 1.4% for the overall incidence of extremely low birthweight infants in the USA 14 (table 2) . Ninety-nine per cent of babies with PWS had difficulty feeding (table 2) and 75% needed supplementation with feeding tube (table 2) . Among the babies with PWS who needed help with a feeding tube, 25% required invasive gastrostomy tube placement and 75% needed a nasogastric or orogastric tube (table 2) . Only 22% of the babies were breast fed in our study population.
We found that PWS babies were born to mothers with a mean age of 31.4 (range 16-47) years, a mean pre-pregnancy weight of 63.8 kg and a mean weight gain of 13.9 kg during pregnancy. Eighteen per cent of mothers reported polyhydramnios during the pregnancy and 5% had oligohydramnios. Four per cent of mothers had gestational diabetes, 6% with high blood pressures during pregnancy but only 1% had pre-eclampsia. Eight per cent of mothers reported premature rupture of membranes, 4% had an abnormal placenta (four had abnormal placental location (three placenta previa and one with low-lying placenta)), three had placental insufficiency, two had calcified placentae, one had a postmature placenta, two had abruptio placentae, one had a thickened placenta and two had unspecified placental abnormalities. Gestational age at birth ranged from 25 to 44 weeks with a mean of 37.9 weeks and 25% of the babies were born prematurely (<37 weeks). Mean Apgar scores were 6.5 at 1 min and 8 at 5 min. Babies with PWS had a range of birth length from 17 to 60 cm (mean of 48.7 cm) and head circumference of 25-42 cm (mean of 34.2 cm). A weak cry was noted in 95%, hypotonia in 99.7% and feeding difficulty in 99%, the most consistent clinical features in our study. Although most of these babies suffered from failure to thrive (77%) and several with gastro-oesophageal reflux disease (24%), about 5% were overweight before their first birthday (table 2) .
Comparison of the variables by genetic subtype
We compared all maternal and neonatal outcome variables by their PWS genetic subtype (deletion, UPD or imprinting defect (ID). No significant differences were found in incidence of maternal complications across the three genetic subtypes except for a significant difference in the mother's pre-pregnancy weight (p=0.01) and maternal age (p<0.0001) with an increased weight and age noted in the mothers of those babies with UPD. There was no difference in the neonatal outcomes in the three genetic subtypes (table 3) .
We also combined the UPD and ID and compared the frequency of the factors with the 15q11-q13 deletion group. Mother's weight before pregnancy (p=0.015) and the maternal age (p<0.0001) continued to be significantly different between the two genetic subtype groups. Patients from the combined UPD and ID group were born to mothers who were older (34.8 years vs 29.2 years) and had a higher mean pre-pregnancy weight (66.2 kg vs 62.3 kg), indicating that advanced maternal age and pre-pregnancy overweight/obesity increase the risk particularly for the UPD group. Additionally, a weak cry was noted to be slightly more frequent in the deletion subtype (97%) babies compared with in the combined group (92%, p=0.048). All of the other maternal and neonatal outcome variables showed no differences between the deletion and combined UPD and ID subtypes.
dIsCussIOn
Prader et al first recognised and described the PWS in 1956. 15 Holm et al later established the PWS clinical diagnostic criteria 
Genotype-phenotype correlations
which was revised in 1993 16 17 and again in 2001 due to significant advances in genetic testing and assessments. 18 Gillessen-Kaesbach et al showed that babies with PWS from Germany due to UPD had a significantly higher birth weight; however, Gunay-Aygun et al showed that the reverse was true in babies from the USA. Varela et al found no statistically significant difference regarding these parameters in babies with PWS from Brazil. [19] [20] [21] [22] In term infants the incidence of low birth weight was higher in our PWS cohort group (34%) versus the population rate of 8.1% in the USA. 14 In our study, however, we did not find any significant difference in birth weight, length or head circumference in babies by PWS genetic subtype. Whittington et al 10 reported perinatal features of PWS in 46 UK babies, which was similar to the present study where we found a significant difference between the PWS genetic subtypes for mother's age and birth weight. In our study, we also found a similar correlation between UPD and maternal age (35.2 years for UPD vs 29.1 years for the deletion group) but we did not find any difference in birth weight. 10 Dudley and Muscatelli 11 reported a significantly higher rate of miscarriage, polyhydramnios (27%), induced labour, caesarean section (53%), low birth weight (37%), hypotonia (97%) and poor nippling (83%) in a French population of PWS. They also found significant differences between PWS genetic subtypes for higher rate of induced labour (79% vs 48%), prematurity (26% vs 8%) and older maternal age in UPD (36.4 years vs 29.3 years) and lower birth weight for newborns with deletion, concluding a significant antenatal complication rate associated with UPD but more significant weight abnormalities associated with the deletion subtype of PWS. 11 Our study confirms similar rates of caesarean section (55%), hypotonia (99.7%) and low birth weight (34%), but showed a lower risk for polyhydramnios (18%) and a higher risk for feeding difficulty (99%) as in previous studies. Our study also confirms that patients with UPD are born to older mothers with higher pre-pregnancy weights compared with patients with the 15q11-q13 deletion lending support to non-disjunction-associated trisomy rescue in the aetiology of PWS UPD; the rates of prematurity and low birth weight however were found to be similar by genetic subtype in our study population. Hiroi et al 23 described abnormal ultradian heart rhythm of fetuses with PWS, which could be an early sign of PWS. Abnormal heart rate or rhythm may increase the risk for preterm induction of labour and emergency delivery by caesarean section. Our study did not look at incidence of abnormal heart rate but had significantly higher rate of caesarean deliveries compared with the general population per CDC statistics (54% vs 32%).
14 High caesarean section rates can be associated with PWS perinatal complications like polyhydramnios, decreased fetal movements and abnormal heart rate/rhythm. Polyhydramnios is seen in about 1%-3% of pregnancies which could be a sign of underlying maternal or fetal disease and contribute significantly to perinatal morbidity and mortality in both mothers and babies. 24 A recently published retrospective matched case-control study by Suleiman and Salim found polyhydramnios to be an independent risk factor for a caesarean delivery. 25 Our study found 18% of patients with PWS had polyhydramnios prenatally which is significantly higher than the general population. Decreased fetal movements were added as one of the minor diagnostic criteria by Holm et al 17 . Decreased fetal movements were also seen in 78% of our study population which is similar to previous reports. 10 11 26 27 In summary, our study reported the incidence of perinatal features in a large cohort of individuals with PWS. We found a high incidence of decreased fetal movements and delivery by caesarean section compared with the general population. Babies with PWS were also found to be at a high risk for low birth weight (<2500 g) in babies delivered at term (34%) and preterm (<37 weeks) (38.2%). Hypotonia, a weak cry and feeding Genotype-phenotype correlations difficulties were the most consistent clinical features of PWS in the newborn period. Most of the babies with feeding difficulties required assistance and the use of a feeding tube with 25% requiring gastrostomy tube placement. There were no significant intergenetic PWS subtype differences except for maternal age and pre-pregnancy maternal weight being significantly higher in the UPD group supporting meiotic non-disjunction and associated trisomy rescue events in early pregnancy.
